Moreover, this effect was not dependent on NLRP3, caspase-1, and caspase-8, but rather on the release of caspase-4, implying the involvement of the non-canonical inflammasome pathway in PBMCs obtained from unstable/exacerbated COPD patients. This evidence concerns the gene CASP4 and chronic obstructive pulmonary disease.